BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

31 related articles for article (PubMed ID: 8250811)

  • 1. Shiga toxin binds human platelets via globotriaosylceramide (Pk antigen) and a novel platelet glycosphingolipid.
    Cooling LL; Walker KE; Gille T; Koerner TA
    Infect Immun; 1998 Sep; 66(9):4355-66. PubMed ID: 9712788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of Cytokine-Induced Glycosylation Changes in Regulating Cell Interactions and Cell Signaling in Inflammatory Diseases and Cancer.
    Dewald JH; Colomb F; Bobowski-Gerard M; Groux-Degroote S; Delannoy P
    Cells; 2016 Nov; 5(4):. PubMed ID: 27916834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemolytic uremic syndrome: toxins, vessels, and inflammation.
    Cheung V; Trachtman H
    Front Med (Lausanne); 2014; 1():42. PubMed ID: 25593915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Shiga toxin pathogenesis: kidney complications and renal failure.
    Obrig TG; Karpman D
    Curr Top Microbiol Immunol; 2012; 357():105-36. PubMed ID: 21983749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigallocatechin-3-gallate suppresses galactose-alpha1,4-galactose-1beta,4-glucose ceramide expression in TNF-alpha stimulated human intestinal epithelial cells through inhibition of MAPKs and NF-kappaB.
    Moon DO; Choi SR; Lee CM; Kim GY; Lee HJ; Park YM
    J Korean Med Sci; 2005 Aug; 20(4):548-54. PubMed ID: 16100442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pretreatment of mice with lipopolysaccharide (LPS) or IL-1beta exerts dose-dependent opposite effects on Shiga toxin-2 lethality.
    Palermo M; Alves-Rosa F; Rubel C; Fernández GC; Fernández-Alonso G; Alberto F; Rivas M; Isturiz M
    Clin Exp Immunol; 2000 Jan; 119(1):77-83. PubMed ID: 10606967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Responses of human intestinal microvascular endothelial cells to Shiga toxins 1 and 2 and pathogenesis of hemorrhagic colitis.
    Jacewicz MS; Acheson DW; Binion DG; West GA; Lincicome LL; Fiocchi C; Keusch GT
    Infect Immun; 1999 Mar; 67(3):1439-44. PubMed ID: 10024592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycolipid receptors for verotoxin and Helicobacter pylori: role in pathology.
    Lingwood CA
    Biochim Biophys Acta; 1999 Oct; 1455(2-3):375-86. PubMed ID: 10571026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Verotoxin/globotriaosyl ceramide recognition: angiopathy, angiogenesis and antineoplasia.
    Lingwood CA
    Biosci Rep; 1999 Oct; 19(5):345-54. PubMed ID: 10763802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor necrosis factor and interleukin 1 induce expression of the glycolipid verotoxin receptor in human endothelial cells. Implications for the pathogenesis of the haemolytic uraemic syndrome.
    Van de Kar NC; Monnens LA; Van Hinsbergh VW
    Behring Inst Mitt; 1993 Aug; (92):202-9. PubMed ID: 8250811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor necrosis factor and interleukin-1 induce expression of the verocytotoxin receptor globotriaosylceramide on human endothelial cells: implications for the pathogenesis of the hemolytic uremic syndrome.
    van de Kar NC; Monnens LA; Karmali MA; van Hinsbergh VW
    Blood; 1992 Dec; 80(11):2755-64. PubMed ID: 1333300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor necrosis factor alpha induces endothelial galactosyl transferase activity and verocytotoxin receptors. Role of specific tumor necrosis factor receptors and protein kinase C.
    van de Kar NC; Kooistra T; Vermeer M; Lesslauer W; Monnens LA; van Hinsbergh VW
    Blood; 1995 Feb; 85(3):734-43. PubMed ID: 7530504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of Shiga toxins with human brain microvascular endothelial cells: cytokines as sensitizing agents.
    Ramegowda B; Samuel JE; Tesh VL
    J Infect Dis; 1999 Oct; 180(4):1205-13. PubMed ID: 10479149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of TNF alpha on verocytotoxin cytotoxicity in purified human glomerular microvascular endothelial cells.
    van Setten PA; van Hinsbergh VW; van der Velden TJ; van de Kar NC; Vermeer M; Mahan JD; Assmann KJ; van den Heuvel LP; Monnens LA
    Kidney Int; 1997 Apr; 51(4):1245-56. PubMed ID: 9083293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of verocytotoxin-1 on nonadherent human monocytes: binding characteristics, protein synthesis, and induction of cytokine release.
    van Setten PA; Monnens LA; Verstraten RG; van den Heuvel LP; van Hinsbergh VW
    Blood; 1996 Jul; 88(1):174-83. PubMed ID: 8704172
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.